These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A preliminary controlled trial of cognitive behavioral therapy in clozapine-resistant schizophrenia.
    Author: Barretto EM, Kayo M, Avrichir BS, Sa AR, Camargo Md, Napolitano IC, Nery FG, Pinto JA, Bannwart S, Scemes S, Di Sarno E, Elkis H.
    Journal: J Nerv Ment Dis; 2009 Nov; 197(11):865-8. PubMed ID: 19996727.
    Abstract:
    The use of cognitive-behavior therapy (CBT) in addition to antipsychotic regimen to treat persistent psychotic symptoms of schizophrenia is growing. The aim of this study was to compare the efficacy of CBT to a befriending (BF) control group in patients with schizophrenia who are refractory to clozapine. Twenty-one patients completed the 21-week trial. In comparison with the control group, the CBT group showed a significant improvement in the General Psychopathology and total score of the Positive and Negative Syndrome Scale, as well as an improvement of Quality of Life scale. The improvement in psychopathology persisted at 6-month follow-up assessment.
    [Abstract] [Full Text] [Related] [New Search]